1-(1-(3-(3-Hydroxyphenoxy)benzyl)piperidin-4-yl)-5-methylpyrimidine-2,4(1H,3H)-dione

ID: ALA4873917

PubChem CID: 164626104

Max Phase: Preclinical

Molecular Formula: C23H25N3O4

Molecular Weight: 407.47

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  Cc1cn(C2CCN(Cc3cccc(Oc4cccc(O)c4)c3)CC2)c(=O)[nH]c1=O

Standard InChI:  InChI=1S/C23H25N3O4/c1-16-14-26(23(29)24-22(16)28)18-8-10-25(11-9-18)15-17-4-2-6-20(12-17)30-21-7-3-5-19(27)13-21/h2-7,12-14,18,27H,8-11,15H2,1H3,(H,24,28,29)

Standard InChI Key:  RCTVTOQDWGJTAI-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 30 33  0  0  0  0  0  0  0  0999 V2000
   12.4422   -2.4226    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.4410   -3.2422    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.1491   -3.6511    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.8587   -3.2417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.8559   -2.4190    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.1473   -2.0138    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.5671   -3.6492    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   15.2742   -3.2395    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.9827   -3.6495    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.6893   -3.2404    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.6885   -2.4224    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.9752   -2.0151    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.2715   -2.4264    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.3975   -3.6483    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.1047   -3.2389    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   18.8122   -3.6520    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.5173   -3.2461    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.5207   -2.4286    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.8127   -2.0186    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.1013   -2.4261    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.2295   -2.0219    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   20.9353   -2.4366    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.6419   -2.0334    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.6484   -1.2159    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.9419   -0.8032    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   20.2291   -1.2081    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.3470   -2.4466    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.3587   -0.8119    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   19.5227   -0.7971    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   11.7330   -3.6502    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  1  1  0
  4  7  1  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13  8  1  0
 10 14  1  0
 14 15  1  0
 15 16  1  0
 15 20  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 18 21  1  0
 21 22  1  0
 21 26  1  0
 22 23  2  0
 23 24  1  0
 24 25  1  0
 25 26  1  0
 23 27  1  0
 24 28  2  0
 26 29  2  0
  2 30  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4873917

    ---

Associated Targets(Human)

MRC5 (9203 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

tmk Thymidylate kinase (360 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Mycobacterium tuberculosis (203094 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Biocomponents

Calculated Properties

Molecular Weight: 407.47Molecular Weight (Monoisotopic): 407.1845AlogP: 3.18#Rotatable Bonds: 5
Polar Surface Area: 87.56Molecular Species: NEUTRALHBA: 6HBD: 2
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 9.11CX Basic pKa: 7.99CX LogP: 2.39CX LogD: 1.99
Aromatic Rings: 3Heavy Atoms: 30QED Weighted: 0.68Np Likeness Score: -0.61

References

1. Song L, Merceron R, Hulpia F, Lucía A, Gracia B, Jian Y, Risseeuw MDP, Verstraelen T, Cos P, Aínsa JA, Boshoff HI, Munier-Lehmann H, Savvides SN, Van Calenbergh S..  (2021)  Structure-aided optimization of non-nucleoside M. tuberculosis thymidylate kinase inhibitors.,  225  [PMID:34450493] [10.1016/j.ejmech.2021.113784]

Source